We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Fraunhofer IZI Selects Lonza’s MODA-ES® Solution To Digitalize Manufacturing Operations

Lonza logo

Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Fraunhofer IZI Selects Lonza’s MODA-ES® Solution To Digitalize Manufacturing Operations"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Fraunhofer IZI intends to digitalize its manufacturing operations with MODA-ES®, the Manufacturing Execution System from Lonza. Fraunhofer IZI will use Lonza’s MODA-ES® to facilitate its transition from an entirely paper-based, manual documentation process to an automated, fully electronic GMP-compliant system.


Manufacturing cell and gene therapies — advanced therapy medicinal products — requires extensive documentation of all manufacturing and verification steps to ensure patient safety and GMP compliance. For organizations with complex workflows, selecting the right electronic batch record solution is critical.


Dr. Gerno Schmiedeknecht, Head of the Department GMP Cell and Gene Therapy, Fraunhofer IZI, commented: "With the introduction of fully electronic batch documentation, manufacturing and batch release for our customers and partners will be even safer, faster, more cost-effective and generally more efficient. In addition, this measure leads to higher flexibility in a potential pandemic situation, as the process of reviewing the batch documentation and the batch release, in particular, can largely be carried out in remote mode without direct onsite presence."


David McErlane, SVP, Head of Bioscience, Lonza, added: "We are excited to support Fraunhofer IZI with their MODA-ES® Implementation. Electronic batch records have been unattainable to most of the industry due to cost constraints and flexibility concerns. With a deep understanding of the challenges faced by cell and gene manufacturers, we designed MODA-ES® with the end user in mind to provide a cost-effective and usable solution that meets our customers’ requirements."


The MODA® Platform bridges the gap between manufacturing and quality control, providing a mechanism to produce a single electronic batch record. Lonza’s manufacturing and lab execution software enables data capture and provides workflow and analytical tools to expedite product release. With a focus on a user-centric, scalable solution that may be implemented in an accelerated timeline, the MODA® Platform supports customers in their efforts to realize their digitalization goals


Advertisement